Search for Clinical Trial Results
Mucocutaneous Lymph Node Syndrome - 25 Studies Found
Status | Study |
Completed |
Study Name: Infliximab Plus Intravenous Immunoglobulin for the Primary Treatment of Kawasaki Disease Condition: Kawasaki Disease Date: 2008-09-25 Interventions:
|
Completed |
Study Name: Epidemiologic Features of Kawasaki Disease in Shanghai From 2008 Through 2012 Condition: Kawasaki Disease Date: 2014-12-08 |
Recruiting |
Study Name: A Multi-center, Randomized to Compare the Efficacy of IVIG Alone and IVIG Plus High-dose Aspirin in Kawasaki Disease Condition: Kawasaki Disease Date: 2016-10-28 Interventions:
|
Withdrawn |
Study Name: Study of Efficacy and Safety of Canakinumab in Pediatric Patients With Kawasaki Disease Condition: Kawasaki Disease Date: 2016-10-24 Interventions: Drug: Canakinumab Other Name: ACZ885 |
Recruiting |
Study Name: Etiology Study of Kawasaki Disease Condition: Kawasaki Disease Date: 2005-09-09 |
Completed |
Study Name: Infliximab (Remicade) for Patients With Acute Kawasaki Disease Condition: Kawasaki Disease Date: 2005-12-30 Interventions:
|
Completed |
Study Name: Study of Combined Therapy of Aspirin and "IVIG-SN" in Kawasaki Disease Condition: Kawasaki Disease Date: 2012-01-25 Interventions: Drug: immunoglobulin G Intravenously administer a single dose of the product (2g/kg) for at least 12 hou |
Completed |
Study Name: A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease Condition: Kawasaki Disease Date: 2005-09-09 Interventions: Drug: Sestamibi Sestamibi Other Name: Cardiolite |
Completed |
Study Name: Clinical Study of TA-650 in Patients With Refractory Kawasaki Disease Condition: Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin Date: 2012-05-09 Interventions:
|
Recruiting |
Study Name: Anakinra and Kawasaki Disease Condition:
Date: 2015-03-11 Interventions: Drug: Anakinra The dose of Anakinra will be 2mg/kg. If the patient remains febrile (fever >38°C) |